Mansukh means Business, conceals Identity to confront a Doctor on Duty

New Delhi: Mansukh Mandaviya, the new Union Health Minister, is in earnest and wants to make public healthcare machinery well oiled so that he measures up to PM Modi’s huge expectations from him. He has launched himself by his surprise visit to a Central Government Health Scheme (CGHS) dispensary concealing his identity. He has come in spotlight but given the enormous amount of work awaiting him, he will have to go way beyond pep talk and occasional surprise detours.

Camouflaged as a regular patient, he chanced upon a doctor in the dispensary who mighty impressed the minister by his compassion and sense of duty. So much so that Mr Mandaviya showcased him as role model and wished him to be emulated by all health workers and sundry in the country. One wonders how Mr Mandaviya would have reacted had he confronted a doctor behaving otherwise.

It is no breaking news that Mr Mansukh means business. His workaholic image is well known. He faces the daunting task of replicating his super PMBJP (Pradhan Mantri Bhartiya Janaushadhi Pariyojana) success in PMJAY(Pradhann Mantri Jan Arogya Yojana also called Ayushman Bharat)as well. In new avatar his moves will be closely watched in public lens.

Regular patients do not have such smooth ride as Mr Mansukh might have got the impression from this surprise visit to the dispensary. He may have failed to read the room but he seems quite happy to start off on a positive note because positivity is what drives Mansukh Mandaviya. It is a harsh reality that things are not honky dory in public healthcare system and, if he wants to be successful as a health minister and wants to keep up his reputation as a game changer, he needs to face the truth bullet.

Some are looking at the event as made up but, as officers working around him would vouch, Mr Mansukh’s sense of commitment is complete which has already been evidenced by his sterling performance in Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP). They say Mr Mandaviya is far from antics.

Doctor on duty is some Dr Arvind Kumar. Mr Mansukh found him polite, compassionate and dutiful despite the fact that he was totally unaware that the patient he was seeing was not an ordinary patient but Union Health Minster himself. Mr Mansukh underlined that nation would need such committed doctors and health workers to make PM Modi’s vision of healthy India a reality. Mandaviya wrote a letter of appreciation in glowing terms to the said doctor and called him to felicitate in the ministry. In a tweet, Mr Mandaviya wrote‘To test the system of CGHS service, I went to a dispensary in Delhi as a normal patient. I am glad that the doctor working there, Arvind Kumar ji’s devotion to duty and his sense of service is inspiring. I appreciate his dedication towards his work.

Related Posts

Will ‘Epidemic’ of Bridge Collapse in Bihar halt with new Minister in?

Hope floats for good ‘Health’ of Bridges, Flyovers & Roads in the state Patna/ New Delhi: Talking of bridges, roads and flyovers in terms of ‘health’ may sound a bit…

Patient dies after oxygen supply stops in ambulance

Family stages protest outside hospital mortuary, demands action A 20-year-old patient referred from Pali to Jodhpur died in an ambulance after the oxygen supply reportedly stopped midway. Following the incident,…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Commissioner FDA reviews enforcement measures

Commissioner FDA reviews enforcement measures

Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years

CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years

Piramal Pharma Gets 3 USFDA Observations at US Facility

Piramal Pharma Gets 3 USFDA Observations at US Facility

Eli Lilly pauses Indian obesity awareness campaign after regulatory notices

Eli Lilly pauses Indian obesity awareness campaign after regulatory notices